These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 30071877)
21. Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination. Dhorda M; Amaratunga C; Dondorp AM Curr Opin Infect Dis; 2021 Oct; 34(5):432-439. PubMed ID: 34267045 [TBL] [Abstract][Full Text] [Related]
22. Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. Mihreteab S; Platon L; Berhane A; Stokes BH; Warsame M; Campagne P; Criscuolo A; Ma L; Petiot N; Doderer-Lang C; Legrand E; Ward KE; Zehaie Kassahun A; Ringwald P; Fidock DA; Ménard D N Engl J Med; 2023 Sep; 389(13):1191-1202. PubMed ID: 37754284 [TBL] [Abstract][Full Text] [Related]
23. Assessment of household ownership of bed nets in areas with and without artemisinin resistance containment measures in Myanmar. Maung TM; Oo T; Wai KT; Hlaing T; Owiti P; Kumar B; Shewade HD; Zachariah R; Thi A Infect Dis Poverty; 2018 Mar; 7(1):19. PubMed ID: 29571301 [TBL] [Abstract][Full Text] [Related]
24. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission. Graves PM; Gelband H; Garner P Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791 [TBL] [Abstract][Full Text] [Related]
25. Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response. Zhu L; van der Pluijm RW; Kucharski M; Nayak S; Tripathi J; White NJ; Day NPJ; Faiz A; Phyo AP; Amaratunga C; Lek D; Ashley EA; Nosten F; Smithuis F; Ginsburg H; von Seidlein L; Lin K; Imwong M; Chotivanich K; Mayxay M; Dhorda M; Nguyen HC; Nguyen TNT; Miotto O; Newton PN; Jittamala P; Tripura R; Pukrittayakamee S; Peto TJ; Hien TT; Dondorp AM; Bozdech Z Commun Biol; 2022 Mar; 5(1):274. PubMed ID: 35347215 [TBL] [Abstract][Full Text] [Related]
26. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission. Graves PM; Choi L; Gelband H; Garner P Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008152. PubMed ID: 29393511 [TBL] [Abstract][Full Text] [Related]
27. Evidence of Artemisinin-Resistant Malaria in Africa. Balikagala B; Fukuda N; Ikeda M; Katuro OT; Tachibana SI; Yamauchi M; Opio W; Emoto S; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Mita T N Engl J Med; 2021 Sep; 385(13):1163-1171. PubMed ID: 34551228 [TBL] [Abstract][Full Text] [Related]
28. Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study. Bosman P; Stassijns J; Nackers F; Canier L; Kim N; Khim S; Alipon SC; Chuor Char M; Chea N; Dysoley L; Van den Bergh R; Etienne W; De Smet M; Ménard D; Kindermans JM Malar J; 2014 Oct; 13():394. PubMed ID: 25288380 [TBL] [Abstract][Full Text] [Related]
29. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment. Wilairat P; Kümpornsin K; Chookajorn T Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079 [TBL] [Abstract][Full Text] [Related]
30. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy. Guerra M; Neres R; Salgueiro P; Mendes C; Ndong-Mabale N; Berzosa P; de Sousa B; Arez AP Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795385 [TBL] [Abstract][Full Text] [Related]
31. Global distribution of polymorphisms associated with delayed Plasmodium falciparum parasite clearance following artemisinin treatment: genotyping of archive blood samples. Murai K; Culleton R; Hisaoka T; Endo H; Mita T Parasitol Int; 2015 Jun; 64(3):267-73. PubMed ID: 25449286 [TBL] [Abstract][Full Text] [Related]
33. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach. White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029 [TBL] [Abstract][Full Text] [Related]
34. Assessment of Plasmodium falciparum Artemisinin Resistance Independent of Nima MK; Mukherjee A; Sazed SA; Hossainey MRH; Phru CS; Johora FT; Safeukui I; Saha A; Khan AA; Marma ASP; Ware RE; Mohandas N; Calhoun B; Haque R; Khan WA; Alam MS; Haldar K mBio; 2022 Feb; 13(1):e0344421. PubMed ID: 35073756 [TBL] [Abstract][Full Text] [Related]
35. Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016). Prosser C; Meyer W; Ellis J; Lee R PLoS One; 2018; 13(5):e0197369. PubMed ID: 29813085 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy. Mwaiswelo R; Ngasala B Malar J; 2020 Apr; 19(1):162. PubMed ID: 32316974 [TBL] [Abstract][Full Text] [Related]
37. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Graves PM; Gelband H; Garner P Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199 [TBL] [Abstract][Full Text] [Related]